High-Throughput Screening on Primary Tumor-Associated Microglia and Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy in Glioblastoma.

对原发性肿瘤相关小胶质细胞和巨噬细胞进行高通量筛选，发现 HDAC 抑制剂可增强吞噬作用，是胶质母细胞瘤免疫治疗的有效伙伴